Lincoln National Corp’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,185
Closed -$467K 29
2024
Q1
$467K Sell
4,185
-134
-3% -$16K 0.01% 777
2023
Q4
$560K Buy
4,319
+88
+2% +$12.1K 0.01% 632
2023
Q3
$690K Buy
4,231
+8
+0.2% +$1.41K 0.01% 498
2023
Q2
$774K Sell
4,223
-5,385
-56% -$775K 0.02% 477
2023
Q1
$1.28M Sell
9,608
-1
-0% -$117 0.03% 332
2022
Q4
$763K Buy
+9,609
New +$677K 0.02% 418
2022
Q3
Sell
-5,968
Closed -$327K 871
2022
Q2
$327K Hold
5,968
0.01% 621
2022
Q1
$451K Buy
5,968
+24
+0.4% +$1.64K 0.01% 568
2021
Q4
$443K Sell
5,944
-40
-0.7% -$2.37K 0.01% 562
2021
Q3
$281K Hold
5,984
0.01% 708
2021
Q2
$242K Hold
5,984
0.01% 749
2021
Q1
$246K Buy
+5,984
New +$223K 0.01% 688

Other funds holding ACLS

Lincoln National Corp's ACLS Position: Q2 2024 in Review

Lincoln National Corp sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 4,185 shares — an estimated $467K sold.

Lincoln National Corp first reported a position in ACLS in Q1 2021 and held it in 12 quarters. The position peaked at $1.28M in Q1 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

  • Lincoln National Corp reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 4,185 Axcelis shares in Q2 2024, an estimated $467K.
  • Lincoln National Corp first reported a position in Axcelis in Q1 2021 and held it in 12 quarters.
  • Lincoln National Corp's Axcelis position peaked at $1.28M in Q1 2023.
  • 392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.